DUBLIN and BRIDGEWATER, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced financial and operational results for the second quarter of 2025.

Detailed price information for Mama's Creations Inc (MAMA-Q) from The Globe and Mail including charting and trades.

Amarin Corporation AMRN reported a loss of 3 cents per share for the second quarter of 2025, which was significantly narrower ...

We expect investors to focus on the sales performance of Amarin Corporation’s AMRN sole marketed drug, Vascepa/Vazkepa, when ...

Amarin Corp. PLC (AMRN) on Wednesday reported a second-quarter loss of $14.1 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Dublin-based company said it ...

Q2 2025 Management View Aaron D. Berg, President and CEO, highlighted Q2 2025 as a “pivotal quarter for Amarin, marked by ...

Amarin Corp PLC (NASDAQ:AMRN) is set to release its Q2 2025 earnings on July 30, 2025. The consensus estimate for Q2 2025 revenue is $53.79 million, and the earnings are expected to come in at -$0.69 ...

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) ...

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) ...